144 related articles for article (PubMed ID: 10959087)
1. Mechanism and relevance of ploidy in neuroblastoma.
Kaneko Y; Knudson AG
Genes Chromosomes Cancer; 2000 Oct; 29(2):89-95. PubMed ID: 10959087
[TBL] [Abstract][Full Text] [Related]
2. Centrosome amplification is correlated with ploidy divergence, but not with MYCN amplification, in neuroblastoma tumors.
Fukushi D; Watanabe N; Kasai F; Haruta M; Kikuchi A; Kikuta A; Kato K; Nakadate H; Tsunematsu Y; Kaneko Y
Cancer Genet Cytogenet; 2009 Jan; 188(1):32-41. PubMed ID: 19061778
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
[TBL] [Abstract][Full Text] [Related]
4. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
[TBL] [Abstract][Full Text] [Related]
5. RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients.
Haruta M; Kamijo T; Nakagawara A; Kaneko Y
Cancer Lett; 2014 Jun; 348(1-2):167-76. PubMed ID: 24680815
[TBL] [Abstract][Full Text] [Related]
6. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy in neuroblastoma.
Eckschlager T; Pilát D; Kodet R; Dahbiová R; Stanková J; Jasinská J; Hrusák O
Neoplasma; 1996; 43(1):23-6. PubMed ID: 8843955
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma.
Mora J; Lavarino C; Alaminos M; Cheung NK; Ríos J; de Torres C; Illei P; Juan G; Gerald WL
Genes Chromosomes Cancer; 2007 Apr; 46(4):385-96. PubMed ID: 17243159
[TBL] [Abstract][Full Text] [Related]
9. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma.
Ambros IM; Zellner A; Roald B; Amann G; Ladenstein R; Printz D; Gadner H; Ambros PF
N Engl J Med; 1996 Jun; 334(23):1505-11. PubMed ID: 8618605
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of DNA ploidy for neuroblastoma.
Nakazawa M
Surg Today; 1993; 23(3):215-9. PubMed ID: 8467172
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Look AT; Hayes FA; Shuster JJ; Douglass EC; Castleberry RP; Bowman LC; Smith EI; Brodeur GM
J Clin Oncol; 1991 Apr; 9(4):581-91. PubMed ID: 2066755
[TBL] [Abstract][Full Text] [Related]
12. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis.
Oppedal BR; Storm-Mathisen I; Lie SO; Brandtzaeg P
Cancer; 1988 Aug; 62(4):772-80. PubMed ID: 3395959
[TBL] [Abstract][Full Text] [Related]
14. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
Oppedal BR; Oien O; Jahnsen T; Brandtzaeg P
J Clin Pathol; 1989 Nov; 42(11):1148-52. PubMed ID: 2584426
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study of prognostic value of DNA ploidy and proliferative activity in neuroblastoma.
Huddart SN; Muir KR; Parkes SE; Mann JR; Stevens MC; Raafat F; Smith K
J Clin Pathol; 1993 Dec; 46(12):1101-4. PubMed ID: 8282832
[TBL] [Abstract][Full Text] [Related]
17. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity and clonal evolution in neuroblastoma.
Mora J; Cheung NK; Gerald WL
Br J Cancer; 2001 Jul; 85(2):182-9. PubMed ID: 11461074
[TBL] [Abstract][Full Text] [Related]
19. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA analysis of neuroblastoma: correlation with prognostic variables and survival of patients.
Suzuki H; Takeuchi K
Jpn J Surg; 1988 Jan; 18(1):116-8. PubMed ID: 3386067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
